Skip to main content

Find Clinical Trials

Home
Conditions
Rhabdoviridae Infections

Clinical trial condition

Rhabdoviridae Infections

Explore clinical trials studying Rhabdoviridae Infections. Study availability and eligibility vary by location and protocol.

79 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Rhabdoviridae Infections trial results

Completed

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland

NCT04478084

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +4 more
Locations: Investigational Site Number :7640004 Bangkok, Thailand

Investigational Site Number :7640002 Bangkok, Thailand

Investigational Site Number :7640003 Khon Kaen, Thailand

View Trial Details

Completed

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland

NCT04594551

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +4 more
Locations: Investigational site number 7640002 Bangkok, Thailand

Investigational site number 7640001 Bangkok, Thailand

Investigational site number 7640003 Bangkok, Thailand

View Trial Details

Completed

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults

NCT03965962

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +4 more
Locations: Investigational Site Number 2500002 Gières, France

Investigational Site Number 2500001 Rennes, France

View Trial Details

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

NCT03713086

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: University Hospital Ghent Ghent, Belgium

Department of Infectious Diseases and Tropical Medicine (DITM), Medical Center of the University of Munich Munich, Bavaria, Germany

View Trial Details

Completed

Study to Evaluate GR1801's Efficacy and Safety

NCT05846568

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +4 more
Locations: Center for Disease Control and Prevention (CDC) Kunming, Yunnan, China

View Trial Details

Completed

A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.

NCT02545517

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: GSK Investigational Site Vienna, Austria

GSK Investigational Site Munich, Bavaria, Germany

GSK Investigational Site Rostock, Mecklenburg-Vorpommern, Germany

GSK Investigational Site Berlin, Germany

View Trial Details

Completed

Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects

NCT04019444

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +4 more
Locations: The Hope Clinic of Emory University Decatur, Georgia, United States

View Trial Details

Completed

Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally

NCT06433440

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: Mohammad Ismail Peshawar, KPK, Pakistan

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults

NCT04062669

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: GSK Investigational Site South Miami, Florida, United States

GSK Investigational Site Lenexa, Kansas, United States

GSK Investigational Site Baltimore, Maryland, United States

GSK Investigational Site Rochester, New York, United States

View Trial Details

Completed

Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally

NCT05937113

Conditions: Infections, Mononegavirales Infections, RNA Virus Infections, +3 more
Locations: CDC Thai Binh Thái Bình, Vietnam

View Trial Details